Please ensure Javascript is enabled for purposes of website accessibility

Welcome to Regulatory Rapporteur. This site uses cookies. Read our policy.

  • Skip to main content
  • Skip to navigation
Site name
topra-logo

The Organisation for Professionals in Regulatory Affairs

Site name
Mast navigation
  • Become a member
  • Sign in
Search our site
Menu
Close menu
  • Regulatory Rapporteur - March 2026
  • Pharmaceuticals
    • Back to parent navigation item
    • Pharmaceuticals
    • Artificial intelligence
    • ATMP
    • Biologics
    • Chemistry, manufacturing and controls
    • Clinical trials
    • Non-clinical development
    • Oncology
    • Product information
    • Regulatory procedures
  • Veterinary
  • Medical devices
    • Back to parent navigation item
    • Medical devices
    • Combination products
    • In-vitro diagnostics
    • Software
    • Artificial intelligence
  • Industry news
    • Back to parent navigation item
    • Industry news
    • Industry news
      • Back to parent navigation item
      • Industry news
      • Read latest news
      • Video
  • Commentary
    • Back to parent navigation item
    • Commentary
    • Editorials
    • Letters to the Editor
    • Podcasts
  • Collections
    • Back to parent navigation item
    • Collections
    • Interviews
    • Symposium 2024
      • Back to parent navigation item
      • Symposium 2024
      • Annual lecture
    • Symposium 2023
      • Back to parent navigation item
      • Symposium 2023
      • Annual lecture
    • Symposium 2022
      • Back to parent navigation item
      • Symposium 2022
      • Annual lecture
    • Regulatory Careers Live
    • CPD supplements
      • Back to parent navigation item
      • CPD supplements
      • 2021/2022
      • 2020
      • 2019
    • Symposium 2021
      • Back to parent navigation item
      • Symposium 2021
      • Annual lecture
  • JOIN TOPRA
  • topra-logo

    The Organisation for Professionals in Regulatory Affairs

  • Regulatory Rapporteur - March 2026
  • Pharmaceuticals
      • Artificial intelligence
      • ATMP
      • Biologics
      • Chemistry, manufacturing and controls
      • Clinical trials
      • Non-clinical development
      • Oncology
      • Product information
      • Regulatory procedures
    • March front cover HALF
      Regulatory Rapporteur March 2026 – Contents
    • March cover image
      The innovation era: Where biology meets technology
    • Half page-REGRAP-ISSUE 23-1-January 2026
      Regulatory Rapporteur January 2026 – Contents
  • Veterinary
    • Jana Schalansky
      November 2025 – Contents: Veterinary medicines sessions
    • RR-June-2025-half cover _masthead
      June 2025 – Contents
    • June cover image licensed
      Veterinary medicines: Translating regulation into practice
    • RR-Nov-2024-Half-Cover
      November 2024 – Contents: Veterinary medicines sessions
  • Medical devices
      • Combination products
      • In-vitro diagnostics
      • Software
      • Artificial intelligence
    • JamesWillsPhotography-TOPRAAnnualLecture2026-0124
      TOPRA Annual Lecture 2026: The Global Imperative for Responsible AI in Healthcare
    • HTAR - main image
      The EU’s Health Technology Assessment Regulation: Implementation one year on
    • BRIDGE - main image
      Beyond product approval: Bridging the gap between regulatory success and patient access for biosimilars
  • Industry news
      • Industry news
        • Read latest news
        • Video
    • FDA_Ultra rare diseases image
      FDA launches framework for accelerating development of individualised therapies for ultra-rare diseases
    • CE mark image
      MHRA seeks views on indefinite acceptance of CE-marked medical devices
    • ICH M15 image
      New ICH M15 Guideline sets harmonised framework for MIDD
  • Commentary
      • Editorials
      • Letters to the Editor
      • Podcasts
    • March cover image
      The innovation era: Where biology meets technology
    • Final cover image
      MedTech in transition: Regulation, risk and real-world impact
    • TOPRA RR JCA 800x533px (6.4 ratio) (002)
      RegRapPod − InConversation with Parexel
  • Collections
      • Interviews
      • Symposium 2024
        • Annual lecture
      • Symposium 2023
        • Annual lecture
      • Symposium 2022
        • Annual lecture
      • Regulatory Careers Live
      • CPD supplements
        • 2021/2022
        • 2020
        • 2019
      • Symposium 2021
        • Annual lecture
    • Banner_new
      Streamline medical device compliance with BSI Compliance NavigatorSponsored by The UK's National Standards Body
    • AdobeStock_59790119
      The Olaratumab experience
    • AdobeStock_207448226
      Qualification of stride velocity endpoint in Duchenne Muscular Dystrophy
  • JOIN TOPRA
  • More from navigation items

Search results

Your search for EMA OR "European Medicines Agency" found 227 results. Displaying results 1 to 10 | Search Help

Use the filters to refine the results. Or use quotation marks to search for an exact phrase - e.g. "pocket money". Or use NOT to reduce unwanted matches, e.g. Paris NOT Texas, will find matches for Paris, but exclude stories which also have the word Texas.
Filter search

Filters

Keyword

Filter your search

By Type

No selections available

By Regulatory Area

No selections available

By Location

No selections available

By Topics

No selections available

By date

No selections available
  • Date range
  • Save article
    Please Sign in to your account to use this feature
    Navigating Advanced Therapy Medicinal Product regulatory changes: European Medicines Agency and UK guidance updates
    Journal

    Navigating Advanced Therapy Medicinal Product regulatory changes: European Medicines Agency and UK guidance updates

    2026-03-04T17:04:00Z

    This article summarises the implications of the EMA unified guideline, the UK-Post Windsor Framework guidance and proposed revisions to the EU Good Manufacturing Practice Part IV.

  • Save article
    Please Sign in to your account to use this feature
    New European Medicines Agency fees: The effect on veterinary medicines
    Journal

    New European Medicines Agency fees: The effect on veterinary medicines

    2025-06-06T14:07:00Z

    In response to the EMA’s new fee system, this article dicusses the impact on marketing authorisation holders who place veterinary medicines on the market.

  • Save article
    Please Sign in to your account to use this feature
    A key role for the European Medicines Agency in the European Union’s Health Technology Assessment Regulation
    Journal

    A key role for the European Medicines Agency in the European Union’s Health Technology Assessment Regulation

    2024-06-18T09:05:00Z

    Regulatory Rapporteur June 2024 | Volume 21 | No.6 Abstract The need for early collaboration between regulators and European Union’s (EU) Health Technology Assessment (HTA) bodies when developing ‘fit-for-purpose’ evidence generation plans has long been acknowledged, and the ...

  • Save article
    Please Sign in to your account to use this feature
    EMA to address antimicrobial resistance risks from veterinary medicinal products
    Industry news

    EMA to address antimicrobial resistance risks from veterinary medicinal products

    2025-05-13T16:05:00Z

    The European Medicines Agency (EMA) has published a new concept paper outlining plans to assess the risks of humans developing AMR from VMPs via the environment.

  • Save article
    Please Sign in to your account to use this feature
    ​EMA launches #HealthNotHype campaign
    Industry news

    ​EMA launches #HealthNotHype campaign

    2025-10-24T16:28:00Z

    This industry news update shares the EMA’s new social media campaign to raise awareness for GLP-1 medicines.

  • Save article
    Please Sign in to your account to use this feature
    EMA accepts new guidelines on investigational ATMPs
    Industry news

    EMA accepts new guidelines on investigational ATMPs

    2025-02-17T12:54:00Z

    The European Medicines Agency (EMA) has adopted the Guideline on quality, non-clinical and clinical requirements for investigational advanced therapy medicinal products in clinical trials, which officially comes into effect on 1 July 2025.

  • Save article
    Please Sign in to your account to use this feature
    EMA establishes new standard procedure for high-risk medical devices
    Industry news

    EMA establishes new standard procedure for high-risk medical devices

    2025-02-17T13:20:00Z

    The European Medicines Agency (EMA) has established a standard procedure for manufacturers of high-risk Class III and Class IIb medical devices to request scientific advice.

  • Save article
    Please Sign in to your account to use this feature
    ​EMA launches #ItTakesATeam campaign to address medicine shortages
    Industry news

    ​EMA launches #ItTakesATeam campaign to address medicine shortages

    2025-11-24T14:17:00Z

    This industry news update explains the #ItTakesATeam campaign which aims to raise awareness of medicine shortages.

  • Save article
    Please Sign in to your account to use this feature
    FDA and EMA publish guiding principles of good AI practice in drug development
    Industry news

    FDA and EMA publish guiding principles of good AI practice in drug development

    2026-01-27T11:42:00Z

    This industry news updates shares the ten principles of best practice for AI. 

  • Save article
    Please Sign in to your account to use this feature
    Rui Santos Ivo elected as new Chair of the EMA Management Board
    Industry news

    Rui Santos Ivo elected as new Chair of the EMA Management Board

    2025-04-01T15:15:00Z

    Rui Santos Ivo has been elected as the new Chair of the European Medicines Agency (EMA) Management Board. Mr Santos Ivo takes over from Lorraine Nolan, who completed her tenure on 21 March 2025.

  • Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next Page
  • What is Regulatory Affairs?
  • TOPRA Membership
  • Regulatory Rapporteur Editorial Board
  • Regulatory Rapporteur Editorial Area
  • Future Focus Topics
  • FAQs
  • Glossary
  • Privacy Policy
  • ISSN 2755-5070 (online)

    ISSN 1742-8955 (print - legacy)

Regulatory Rapporteur

The peer-reviewed journal, published 11 times per year and available free to TOPRA members.

Follow TOPRA
topra-logo

The Organisation for Professionals in Regulatory Affairs

TOPRA office
TOPRA Publishing, Third floor, City Reach, 5 Greenwich View Place, London E14 9NN, UK
Tel: +44 (0) 20 7510 2560
Email: publications@topra.org

TOPRA AISBL
Blvd du Souverain 280, 1160 Brussels, Belgium
Tel: +32 (0) 2 808 72 70

  • Contact us
  • Copyright © 2015-2026 The Organisation for Professionals in Regulatory Affairs Ltd. t/a Regulatory Rapporteur - All rights reserved

Site powered by Webvision Cloud